Sumitomo Pharma Oncology, Inc., a clinical-stage company focused on novel cancer therapeutics, announced the U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation...
Hansa Biopharma AB, a pioneer in enzyme technology for rare immunological conditions, announces that the Company has entered into an agreement with U.S.-based NovaQuest...
RegeneRx Biopharmaceuticals, Inc., a clinical-stage drug development company focused on tissue protection, repair, and regeneration, is reporting today that its U.S. joint venture (JV)...
Ginkgo Bioworks, the leading horizontal platform for cell programming, announced the launch of a new cell programming project as part of a broader collaboration...
Brii Biosciences Limited a multi-national company developing innovative therapies for diseases with significant unmet medical needs and large public health burdens, announced that TSB...
